BioSpace News Archive

Viatris Inc. (NASDAQ: VTRS) and Kindeva Drug Delivery L.P. today announced that the U.S. Food and Drug Administration (FDA) granted tentative approval of budesonide

INNOVO adds significant incremental investment for pioneering home-based treatment for stress urinary incontinence, a condition that impacts 1 in 3 women worldwide Netherland’s Borski Fund backs female-led, femtech focused companies

Compugen Ltd. (NASDAQ: CGEN), a leader in predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, today announced that management will present at the Oppenheimer 31 st Annual Healthcare Conference (virtual), on Tuesday, March 16 , 2021 at 10:40 AM ET.

Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced that Craig Fraser , president and chief executive officer, will present at the H.C. Wainwright Global Life Sciences Conference

- Plasmatology aims to become the reference publication for plasma science, bringing together the discipline’s knowledge, research and scientific advances that until now lacked a specialized journal

The group of concerned shareholders Concerned Shareholders of FSD Pharma Inc. which includes two founding directors, Anthony Durkacz and Zeeshan Saeed , are pleased to announce that they were successful in their request that the Ontario Superior Court of Justice order the Company to accelerate the date of its previously called annual shareholders meeting.

ReForm Biologics , a company developing a new generation of bio-innovative biologic medicines to improve patient access, safety and convenience, announced the expansion of its patent portfolio with issuance of its first patent in China, Patent No. CN ZL20158003.

-- Follows recent appointments of Barbara Kosacz and Matthew Fust to ArsenalBio’s Board of Directors and Ken Drazan as Chairman of the Board -- -- Expansion of leadership will support programmable cell therapy pioneer’s continued pipeline, business and operations scale-up --

OpGen today announced the release of a new peer-reviewed publication that demonstrates that the Unyvero Hospitalized Pneumonia (HPN) panel is a reliable and rapid diagnostic test with high negative predictive value for the detection of bacterial pathogens directly from native lower respiratory tract samples, allowing identification of bacterial co-infections in hospitalized patients with COVID-19 pneumonia in just five hours.

Minerva today reported key business updates and financial results for the fourth quarter and fiscal year ended December 31, 2020.